These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4461787)

  • 1. Central dopamine neurons and sensory processing.
    Ungerstedt U; Ljungberg T
    J Psychiatr Res; 1974; 11():149-50. PubMed ID: 4461787
    [No Abstract]   [Full Text] [Related]  

  • 2. Central catecholamine neurons, behavior and neuroleptic drugs: an analysis to understand the involvement of catecholamines in schizophrenia.
    Fuxe K; Nyström M; Tovi M; Smith R; Ogren SO
    J Psychiatr Res; 1974; 11():151-61. PubMed ID: 4156786
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical aspects of dopamine agonists.
    Kehr W; Carlsson A; Lindqvist M
    Adv Neurol; 1975; 9():185-95. PubMed ID: 1146653
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography.
    Miller R; Horn A; Iversen L; Pinder R
    Nature; 1974 Jul; 250(463):238-41. PubMed ID: 4368645
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of gamma-hydroxybutyric acid, baclofen, aminooxyacetic acid, and apomorphine on dopamine turnover in corpus striatum and limbic system.
    Andén NE
    Adv Biochem Psychopharmacol; 1977; 16():495-9. PubMed ID: 18898
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of diphenylhydantoin on central catecholamine containing neuronal systems.
    Elliott PN; Jenner P; Chadwick D; Reynolds E; Marsden CD
    J Pharm Pharmacol; 1977 Jan; 29(1):41-3. PubMed ID: 13181
    [No Abstract]   [Full Text] [Related]  

  • 7. Temporal changes in catecholamine synthesis of rat forebrain structures after axotomy.
    Kehr W
    J Neural Transm; 1974; 35(4):307-17. PubMed ID: 4436670
    [No Abstract]   [Full Text] [Related]  

  • 8. Sensory inattention produced by 6-hydroxydopamine-induced degeneration of ascending dopamine neurons in the brain.
    Ljungberg T; Ungerstedt U
    Exp Neurol; 1976 Dec; 53(3):585-600. PubMed ID: 1001389
    [No Abstract]   [Full Text] [Related]  

  • 9. Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.
    Von Voigtlander PF; Moore KE
    Neuropharmacology; 1973 May; 12(5):451-62. PubMed ID: 4145343
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamine synthesis in rat brain after axotomy: interaction between apomorphine and haloperidol.
    Kehr W; Carlsson A; Lindqvist M
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):111-7. PubMed ID: 193050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. d-Amphetamine and gamma-butyrolactone alteration of dopamine synthesis in the terminals of nigrostriatal and mesolimbic neurons. Possible role of various autoreceptor sensitivities.
    Demarest KT; Lawson-Wendling KL; Moore KE
    Biochem Pharmacol; 1983 Feb; 32(4):691-7. PubMed ID: 6403019
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopaminergic supersensitivity in the striatum.
    Ungerstedt U; Ljungberg T; Hoffer B; Siggins G
    Adv Neurol; 1975; 9():57-65. PubMed ID: 167568
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine release and direct dopamine receptor activation in the central nervous system by D-145, an amantadine derivative.
    Svensson TH
    Eur J Pharmacol; 1973 Sep; 23(3):232-8. PubMed ID: 4746740
    [No Abstract]   [Full Text] [Related]  

  • 15. The dopamine hypothesis of schizophrenia: a review.
    Meltzer HY; Stahl SM
    Schizophr Bull; 1976; 2(1):19-76. PubMed ID: 779020
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurochemical and behavioral effects of acute and chronic treatment with apomorphine in rats.
    Rowlett JK; Mattingly BA; Bardo MT
    Neuropharmacology; 1991 Feb; 30(2):191-7. PubMed ID: 1903190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some benzhydryl derivatives as central dopamine receptor stimulating agents.
    van Beek MC; Timmerman H
    J Pharm Pharmacol; 1974 Jan; 26(1):57-8. PubMed ID: 4150936
    [No Abstract]   [Full Text] [Related]  

  • 18. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
    Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracranial self-stimulation in rats as a function of various stimulus parameters. V. Influence of cocaine on medial forebrain bundle stimulation with monopolar electrodes.
    Wauquier A; Niemergeers CJ
    Psychopharmacologia; 1974; 38(3):201-10. PubMed ID: 4417551
    [No Abstract]   [Full Text] [Related]  

  • 20. Various dose-dependent influences of apomorphine on the acetylcholine turnover in striatum and mesolimbic areas of rat brain.
    Langnickel R; Bluth R; Oelssner W
    Biomed Biochim Acta; 1983; 42(7-8):937-46. PubMed ID: 6651810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.